DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$224.39
−2.03%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$229.01
From 52W high−7.30%
Volume3.05M
Market cap$157.74B
P/E (TTM)39.7x
P/S (TTM)6.3x
Div yield0.68%
Key dataOct 19, 2026
Open
$229.01
From 52W high
−7.30%
Volume
3.05M
Market cap
$157.74B
ValuationView details →
P/E (Fwd)
24.8x
EV/EBITDA
23.7x
P/E (TTM)
39.7x
RSI (14)
56.2
MomentumView details →
1D Return
−2.03%
YTD Return
−1.94%
SummaryUpdated Jun 1, 2026
Danaher Corporation (NYSE:DHR) is a diversified life sciences and diagnostics company founded in 1969 and headquartered in Washington, D.C. Originally established as Diversified Mortgage Investors, Inc., the company underwent a significant transformation and changed its name to Danaher Corporation in 1984. Over the decades, Danaher has evolved from a diversified industrial conglomerate into a focused life sciences powerhouse through strategic acquisitions and divestitures. The company went public in 1978 and has since built a portfolio of leading brands serving the biotechnology, life sciences research, and clinical diagnostics markets worldwide.
Similar companies
Latest newsMore news →
Danaher's Biotechnology segment posted 4% sales growth, though tough comparisons and shipment timing could test its momentum.19d agoChina's Vice Minister of Commerce and International Trade Representative Ling Ji visited Zhongguancun Life Science Park in Beijing and chaired a roundtable with more than 30 foreign-funded enterprises on September 21.28d ago